Previous 10 | Next 10 |
home / stock / alpmf / alpmf news
Conducting biopharmaceutical research initiated by Merck ( MRK ) and with a massive market opportunity, Urovant ( UROV ) seems an interesting name to be followed once the IPO goes live. With that, the facts that the company was incorporated in Cayman and Roivant Sciences Ltd. controls the comp...
The following slide deck was published by Astellas Pharma, Inc. ADR in conjunction with their 2018 Q2 earnings Read more ...
The FDA accepts under Priority Review Astellas Pharma's ( OTCPK:ALPMF )( OTCPK:ALPMY ) marketing application seeking approval for gilteritinib for the treatment of adult patients with relapsed/refractory FLT3-positive acute myeloid leukemia (AML). The agency's action date is November ...
The following slide deck was published by Astellas Pharma, Inc. ADR in conjunction with this Read more ...
Pfizer (NYSE: PFE ) and collaboration partner Astellas Pharma ( OTCPK:ALPMF ) announce that the FDA has accepted under Priority Review the former's marketing application seeking approval for XTANDI (enzalutamide) for the treatment of men with non-metastatic castration-resistant prostate ca...
Noteworthy events for the week of Feb. 4 - 10 for healthcare investors: More news on: Protalix BioTherapeutics, Inc, Bristol-Myers Squibb Company, WellCare Health Plans, Inc., Healthcare stocks news, Read more ...
Astellas Pharma ( OTCPK:ALPMF ): 9M net profit of ¥ 167.88B. More news on: Astellas Pharma, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
Note: Subscribers to Avisol Capital Partners' Total Pharma Tracker got an early look at this publication. Consider becoming a subscriber today to get early access! Welcome to another edition of "3 Things In Biotech You Should Learn Today," a daily digest dedicated to helping you keep p...
Note: Subscribers to Avisol Capital Partners Total Pharma Tracker got an early look at this publication. Welcome to another edition of "3 Things In Biotech You Should Learn Today," a daily digest dedicated to helping you keep pace with the fast-moving world of pharmaceutical and biotec...
News, Short Squeeze, Breakout and More Instantly...
Astellas Pharma Inc Company Name:
ALPMF Stock Symbol:
OTCMKTS Market:
Pharmaceutical stocks were initially expected to be largely immune to the COVID-19 economic downturn. Drugmakers, after all, generally produce products that are essential to daily life. However, the extreme social distancing that has become part and parcel of this unusual period has halted nume...
One of England's top healthcare watchdogs, the National Institute for Health and Care Excellence (NICE), has officially decided to stay the course and reject AstraZeneca 's (NYSE: AZN) lung cancer drug Tagrisso. A few months ago, the pharmaceutical giant argued that the drug should receive...
This past year proved profitable for investors in Incyte (NASDAQ: INCY) and Seattle Genetics (NASDAQ: SGEN) . Handily beating broad market and biotech indexes, these two drug manufacturers hit the $20 billion valuation mark and are poised to continue growing in the coming year -- unless, ...